Targeting glutamate transporter-1 in neurological diseases

Oncotarget. 2017 Apr 4;8(14):22311-22312. doi: 10.18632/oncotarget.16374.

Authors

Jacqueline A Hubbard¹, Devin K Binder¹

Affiliation

¹ Center for Glial-Neuronal Interactions, Division of Biomedical Sciences, School of Medicine, University of California, CA, USA.

No abstract available

Keywords: ALS; Alzheimer’s; EAAT2; GLT1; epilepsy.

Publication types

Editorial

MeSH terms

Alzheimer Disease / metabolism
Amino Acid Transport System X-AG / metabolism*
Amyotrophic Lateral Sclerosis / metabolism
Animals
Astrocytes / metabolism
Disease Progression
Epilepsy / metabolism
Excitatory Amino Acid Transporter 2
Gene Expression Regulation
Glutamate Plasma Membrane Transport Proteins / metabolism
Glutamates / metabolism
Glutamic Acid / metabolism
Homeostasis
Humans
Mice
Models, Biological
Nervous System Diseases / metabolism*
Neurodegenerative Diseases / metabolism

Substances

Amino Acid Transport System X-AG
Excitatory Amino Acid Transporter 2
Glutamate Plasma Membrane Transport Proteins
Glutamates
SLC1A2 protein, human
Glutamic Acid